MicroRNA regulates human vitamin D receptor

Area of Science:

• Molecular Biology
• Gene Regulation
• Cancer Biology

Background:

• Biological effects of 1alpha,25-dihydroxyvitamin D(3) (1,25(OH)(2)D(3)) are mediated by the vitamin D receptor (VDR).
• Previous studies indicated posttranscriptional regulation of VDR due to a lack of correlation between VDR mRNA and protein levels.
• MicroRNAs (miRNAs) are key regulators of gene expression via translational repression or mRNA degradation.

Purpose of the Study:

• To investigate the potential role of miR-125b in the posttranscriptional regulation of the human vitamin D receptor (VDR).
• To determine if miR-125b directly interacts with the VDR mRNA and affects VDR protein levels.
• To assess the functional consequences of miR-125b-mediated VDR regulation on 1,25(OH)(2)D(3) activity.

Main Methods:

• Luciferase assays were performed using a plasmid containing the miR-125b recognition element (MRE125b) in the 3'-untranslated region of VDR mRNA.
• Electrophoretic mobility shift assays (EMSA) were used to assess the effect of miR-125b overexpression on endogenous VDR protein levels.
• Impact of miR-125b on 1,25(OH)(2)D(3)-induced CYP24 mRNA levels and antiproliferative effects in cancer cells (MCF-7) was evaluated.

Main Results:

• Luciferase assays confirmed that miR-125b functionally recognizes the MRE125b in VDR mRNA.
• Overexpression of miR-125b significantly decreased VDR protein levels in MCF-7 cells.
• miR-125b overexpression attenuated 1,25(OH)(2)D(3)-induced CYP24 mRNA expression and abolished its antiproliferative effects.

Conclusions:

• miR-125b posttranscriptionally regulates human VDR by targeting its mRNA.
• The findings suggest that miR-125b represses endogenous VDR levels.
• Downregulation of miR-125b in cancer may lead to VDR upregulation, potentially enhancing the antitumor effects of 1,25(OH)(2)D(3).